Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes

Although many clinical and molecular markers for predicting outcomes in bladder cancer (BC) have been reported, their application in clinical practice remains unclear. Bladder carcinogenesis has two distinct molecular pathways that direct the development of BC. FGFR3 mutations are common in low-grad...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagata, Masayoshi, Muto, Satoru, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746343/
https://www.ncbi.nlm.nih.gov/pubmed/26924873
http://dx.doi.org/10.1155/2016/8205836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746343/
https://www.ncbi.nlm.nih.gov/pubmed/26924873
http://dx.doi.org/10.1155/2016/8205836

Ejemplares similares